UBE2K, similar to RBCK1, acts as a ubiquitin ligase and interacts with c-Myc to play an oncogenic role in HCC progression through the UBE2K/c-Myc axis [26]. This evidence concerns the gene UBE2K and hepatocellular carcinoma.